Response rates, long term outcomes and toxicity profile of gemcitabine and vinorelbine based outpatient chemotherapy regimen in primary progressive and relapsed childhood Hodgkin lymphoma-Reference-Cited by-同舟云学术

Response rates, long term outcomes and toxicity profile of gemcitabine and vinorelbine based outpatient chemotherapy regimen in primary progressive and relapsed childhood Hodgkin lymphoma

Published:2020-09-13 Issue:14 Volume:61 Page:3369-3377
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Jan Mir Rooh Ullah¹,Saeed Haleema¹,Abubakar Muhammad²,Wali Rabia Muhammad¹

Affiliation:

1. Pediatric Oncology Department, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan

2. Research Department, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1817434

Reference29 articles.

1. Relapse after treatment of pediatric hodgkin lymphoma: Outcome and role of surveillance after end of therapy

2. Hodgkin lymphoma in children and adolescents: improving the therapeutic index

3. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma - results of the UK HD3 relapse treatment strategy

4. A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of relapsed and refractory paediatric Hodgkin lymphoma; a 10-year retrospective study of an LMIC;ecancermedicalscience;2024-07-16

2. Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma;Pediatric Blood & Cancer;2022-02-02

3. Gemcitabine/vinorelbine;Reactions Weekly;2021-01